2:25 PM
May 01, 2019
 |  BC Extra  |  Company News

Management tracks: Gilead, bluebird, Apollomics

Gilead Sciences Inc. (NASDAQ:GILD) said Robin Washington will retire as EVP and CFO, effective March 1, 2020. Washington, who joined Gilead in 2008, will continue in her role while the company identifies a successor.

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) promoted Joanne Smith-Farrell to CBO from SVP of corporate development and strategy. She will also continue to serve as oncology franchise leader.

Apollomics Inc. (Foster City, Calif.), which is developing combination therapies for cancer, hired Fabio Benedetti as CMO. Benedetti was...

Read the full 392 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >